Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

Mario Eisenberger is an Oncologist in Baltimore, Maryland. Dr. Eisenberger is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.

Laura Sena, MD, PhD is a medical oncologist specializing in the care of patients with advanced prostate cancer at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University. She obtained MD and PhD degrees from Northwestern University in the Medical Scientist Training Program, then subsequently completed Internal Medicine and Medical Oncology subspecialty training in the Physician Scientist Training Program at Johns Hopkins. The goal of her research is to improve therapies and outcomes for patients with advanced prostate cancer by better understanding how prostate cancer metabolism contributes to disease progression, therapeutic resistance, and tumor immune evasion. Dr. Sena is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, and Hormone Replacement Therapy (HRT).

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Hypogonadism, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Dr. Marisa Clifton is the Director of Women’s Health at the Brady Urological Institute. She is fellowship trained. As a leader in the field of female urology, her clinical expertise includes surgical and nonsurgical treatment of pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, urinary fistulas, genitourinary reconstruction and urethral diverticula. Dr. Clifton is also an Assistant Professor of Urology at the Johns Hopkins School of Medicine and serves as the Director of Robotic Education. In addition, she serves as Vice President of Medical Affairs at Johns Hopkins Bayview Medical Center. She also serves as Associate Chief Medical Officer of The Johns Hopkins Hospital. Her research interests include medical education and clinical outcomes after surgery. Dr. Clifton received her medical degree from the Johns Hopkins University School of Medicine and completed her residency in urology at the Mayo Clinic in Rochester, Minnesota. She completed her fellowship in Female Pelvic Medicine and Reconstructive Surgery at The Cleveland Clinic in Cleveland, Ohio. Dr. Clifton is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Urinary Incontinence, Obstructive Uropathy, Neurogenic Bladder, Sacral Nerve Stimulation, and Hormone Replacement Therapy (HRT).

Wen Shen is an associate professor of clinical gynecology and an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics as well as joint appointmetns in the Kimmel Oncology Center and the Department of General Internal Medicine. She is also the clinical director of the Menopause Consultation service and the director of the Women’s Wellness & Healthy Aging Program. Dr. Shen has concentrated on menopause medicine for more than 20 years. She specializes in treating peri-menopause and menopausal symptoms taking into consideration the woman’s overall health. She often works with her patients’ primary care provider to recommend non-hormonal therapies, alternative treatment options and menopause hormone therapy as appropriate for the individual patient. In addition to clinical care, Dr. Shen focuses on educating her patients, other physicians and future physicians on women’s post reproductive health. She is actively developing curricula and educational aids for future physicians and health care providers on menopause medicine and the importance of healthy aging. Dr. Shen has published numerous articles and book chapters on menopause and perimenopause. She is a fellow of the American College of Obstetricians and Gynecologists and had served on the Board of Trustees for the North American Menopause Society. Dr. Shen earned her Master’s in Public Health and her Medical Degree from the Tulane University School of Medicine. She completed her residency in Gynecology and Obstetrics at The Johns Hopkins Hospital. During the 18 years Dr. Shen spent in general practice she became aware of the lack of physician education on post-reproductive health in women. Since her 2005 return to Johns Hopkins, she has committed herself to raising awareness of menopausal and post-reproductive health in women to help them stay their healthiest beginning in peri-menopause and as they age. Videos Meet Our Experts: Dr. Wen Shen Menopause Webinar - Dr. Wen Shen. Dr. Shen is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Vaginal Cysts, Vaginal Dryness, Thyroidectomy, and Parathyroidectomy.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Charles Lowenstein, M.D., is a cardiologist in Baltimore, Maryland. He also serves as director of the Division of Cardiology and co-director of the Johns Hopkins Heart and Vascular Institute. Dr. Lowenstein originally came to Johns Hopkins as a cardiology fellow in 1991 after completing his medical residency at Massachusetts General Hospital and a research fellowship at the Massachusetts Institute of Technology. In 1993, he joined the Johns Hopkins faculty and helped lead the Ciccarone Center for the Prevention of Heart Disease until he was recruited in 2009 to become the chief of cardiology and director of the Aab Cardiovascular Research Institute at the University of Rochester School of Medicine and Dentistry. In 2020 he was hired to lead the Division of Cardiology at Hopkins. He has served on the NIH Atherosclerosis and Inflammation Cardiovascular Sciences study section, and is a member of the Sarnoff Cardiovascular Research Foundation, an organization that funds medical student research. Dr. Lowenstein’s research focuses on vascular biology, exploring molecular mechanisms of vascular inflammation and thrombosis. Videos Dr. Charles Lowenstein. Dr. Lowenstein is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Long QT Syndrome 3, Heart Attack, Long QT Syndrome 2, Long QT Syndrome 1, and Hormone Replacement Therapy (HRT).

Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Taieri Mckenzie is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Mckenzie is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Preeclampsia, Vaginal Bleeding Between Periods, Vaginal Cysts, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Mckenzie is currently accepting new patients.

Stephanie Pollard is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Pollard has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Vaginal Cysts, Vaginal Dryness, Vaginal Bleeding Between Periods, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Pollard is currently accepting new patients.

Dominique Allen is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Allen is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Pelvic Inflammatory Disease, Vulvovaginitis, Cervical Polyps, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Allen is currently accepting new patients.

Berendena Vander Tuig, M.D., M.P.H., practices obstetrics and gynecology at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Emory University School of Medicine, and completed her residency in obstetrics and gynecology at Johns Hopkins University School of Medicine. Videos Caring for the CommunityMeet Dr. Dena Vander Tuig. Dr. Tuig is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Female Genital Sores, Vaginal Bleeding Between Periods, Vaginal Cysts, Vaginal Dryness, and Hormone Replacement Therapy (HRT).

Dr. Shadpour Demehri is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He specializes in diagnostic radiology and musculoskeletal (MSK) radiology. Dr. Demehri received his M.D. from Tehran University School of Medicine in 2003. He completed a fellowship in radiology at Johns Hopkins University School of Medicine. He performed his residency in diagnostic radiology in 2010 at Brigham & Women’s Hospital, where he subsequently completed two fellowships, one in musculoskeletal and nuclear radiology and a second in noninvasive cardiovascular imaging. He joined the Johns Hopkins faculty in September 2012. Dr. Demehri is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Ollier Disease, Osteotomy, and Aneurysm Repair.

Arthur Burnett is a Urologist in Baltimore, Maryland. Dr. Burnett is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).

Dr. Cybill Esguerra is a clinical instructor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine. Her clinical interests and expertise include general obstetrics, well-woman care, menstrual disorders, contraceptive management, adolescent gynecology, and gynecologic surgery. Dr. Esguerra attended medical school at Saint Louis University School of Medicine and completed her residency in Obstetrics and Gynecology at Robert Wood Johnson University Hospital New Brunswick in New Jersey where she served as Administrative Chief Resident. Dr. Esguerra chose to practice Obstetrics and Gynecology in order to provide continuity of care throughout a woman's lifetime. She strives to deliver compassionate, patient-centered care at the highest medical standards. Outside of the office, Dr. Esguerra enjoys Pilates and exploring new cities. Recent News Articles and Media Coverage Pool Cannonballs Are Pretty Much A No-Go During Pregnancy, Romper (May 2021) The Best Menstrual Cups of 2021, Reviewed (May 2021). Dr. Esguerra is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Tubal Ligation and Hormone Replacement Therapy (HRT).